Financial Statements
Financial Statements

Bayer Group Consolidated Statements of Cash Flows

 [Table 22]
 2nd Quarter
2009
2nd Quarter
2010
1st Half
2009
1st Half
2010
 € million€ million€ million€ million
Income after taxes5305249541,218
Income taxes199220414479
Non-operating result292261626505
Income taxes paid or accrued(233)(400)(565)(819)
Depreciation and amortization6887891,3761,433
Change in pension provisions(97)(89)(214)(234)
(Gains) losses on retirements of noncurrent assets(131)(19)(134)(25)
Gross cash flow1,2481,2862,4572,557
     
Decrease (increase) in inventories257195375(17)
Decrease (increase) in trade accounts receivable(126)221(798)(899)
(Decrease) increase in trade accounts payable491(414)200
Changes in other working capital, other non-cash items(29)(158)472436
Net cash provided by (used in) operating activities (net cash flow)1,3991,5452,0922,277
     
Cash outflows for additions to property, plant, equipment and intangible assets(370)(365)(660)(595)
Cash inflows from sales of property, plant, equipment and other assets8122325
Cash inflows from (outflows for) divestitures51245141
Cash inflows from (outflows for) noncurrent financial assets(53)(133)84(243)
Cash outflows for acquisitions less acquired cash(2)(1)(2)(18)
Interest and dividends received20123233
Cash inflows from (outflows for) current financial assets(3)24(7)17
Net cash provided by (used in) investing activities(349)(427)(479)(740)
     
Capital contributions0000
Dividend payments and withholding tax on dividends(969)(1,158)(973)(1,158)
Issuances of debt1913742,552491
Retirements of debt(2,342)(624)(2,878)(771)
Interest paid including interest rate swaps(650)(423)(819)(519)
Interest received from interest rate swaps231218283229
Payments for the subsequent purchase of ownership interests in subsidiaries(40)0(40)0
Net cash provided by (used in) financing activities(3,579)(1,613)(1,875)(1,728)
     
Change in cash and cash equivalents due to business activities(2,529)(495)(262)(191)
     
Cash and cash equivalents at beginning of period4,3653,0412,0942,725
     
Change in cash and cash equivalents due to changes in scope of consolidation1030
Change in cash and cash equivalents due to exchange rate movements(3)5(1)17
     
Cash and cash equivalents at end of period1,8342,5511,8342,551
2009 figures restated
http://www.stockholders-newsletter-q2-2010.bayer.com/en/cash-flows.aspx

Copyright © Bayer AG

Print Page

Search

Download Center

Publications

Services

Special Interest